Form 8-K · Current Report · Filed 2025-10-22
Thermo Fisher Scientific Reports 5% Revenue Growth and 10% Adjusted EPS Growth in Q3 2025
Thermo Fisher Scientific Inc. announced its financial results for the third quarter of 2025, reporting a 5% increase in revenue to $11.12 billion. The company achieved a GAAP diluted EPS of $4.27 and an adjusted EPS of $5.79, reflecting a 10% growth from the same period in the previous year. The earnings release, furnished as Exhibit 99.1, highlighted operational performance, new product launches, strategic collaborations, and acquisitions that contributed to the company's financial success.
- Filer
- Thermo Fisher Scientific Inc. TMO · NYSE
- Filed
- Accession
- 0000097745-25-000150
- CIK
- 0000097745
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Results of Operations and Financial Condition
Financial Statements and Exhibits
Market reaction
Close before filing
$557.99
Next session
+2.5%
Since filing
+2.9%
Latest close
$574.30
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from TMO reporting the same item, with the next session's move:
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a world-leading biotechnology company that provides essential tools and services for life sciences, biotechnology, pharmaceutical, and healthcare industries. Renowned for its extensive portfolio, the company specializes in offering innovative laboratory products, analytical instruments, and software solutions critical for research, diagnostics, and clinical applications. Thermo Fisher enables scientists to perform complex experiments with cutting-edge technology, from DNA sequencing and cell analysis to clinical diagnostics and specialty chemicals. Serving a vast array of sectors, the company impacts fields such as diagnostics, genetic engineering, and environmental monitoring. Its strategic acquisitions and collaborations strengthen its market presence, making it a go-to partner for scientific advancements and innovation. With operations spanning over 50 countries, Thermo Fisher plays a pivotal role in driving scientific discovery and improving health outcomes globally.
Never miss another TMO filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.